1346603-62-0

Basic information

• Product Name: Levofloxacin Related CoMpound E
• Synonyms: N,N'-Desethylene Levofloxacin 2;Levofloxacin Related CoMpound E;Levofloxacin Diamine Derivative;(S)-9-fluoro-3-methyl-10-((2-(methylamino)ethyl)amino)-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride;(S)-9-fluoro-3-methyl-10-((2-(methylamino)ethyl)amino)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid hydrochloride;Levofloxacin Impurity B;7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-[[2-(methylamino)ethyl]amino]-7-oxo-, hydrochloride (1:1), (3S)-;Levofloxacin Related Compound E HCl
• CAS NO: 1346603-62-0
• Molecular Formula: C16H19ClFN3O4
• Molecular Weight: 371.7911632
• Mol File: 1346603-62-0.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Levofloxacin Related CoMpound E(CAS DataBase Reference)
• NIST Chemistry Reference: Levofloxacin Related CoMpound E(1346603-62-0)
• EPA Substance Registry System: Levofloxacin Related CoMpound E(1346603-62-0)

Safety Data

• Hazardous Substances Data: 1346603-62-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Levofloxacin Related CoMpound E is used as an impurity reference for [application reason] ensuring the quality and safety of Levofloxacin (L360000) in pharmaceutical formulations. It aids in the identification, quantification, and control of impurities in the manufacturing process, which is crucial for maintaining the drug's efficacy and minimizing potential side effects.
Used in Quality Control and Research:
Levofloxacin Related CoMpound E is used as a reference compound for [application reason] quality control testing and research purposes. It helps in the development of analytical methods for detecting and quantifying impurities in Levofloxacin, as well as in studying the stability and degradation behavior of the drug under various conditions.
Used in Regulatory Compliance:
Levofloxacin Related CoMpound E is used as a regulatory reference for [application reason] ensuring that pharmaceutical companies comply with the United States Pharmacopeia (USP) standards. It is essential for meeting the regulatory requirements for drug quality and safety, which is a critical aspect of the drug approval process and ongoing monitoring.